PrEP Nonadherence, White Coat Dosing, and HIV Risk Among a Cohort of MSM | Zendy

Cheríe Blair | Zendy; Matthew R. Beymer | Zendy; Ryan Kofron | Zendy; Robert Bolan | Zendy; Wilbert Jordan | Zendy; Richard Haubrich | Zendy; Amy Rock Wohl | Zendy; Raphael J. Landovitz | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

PrEP Nonadherence, White Coat Dosing, and HIV Risk Among a Cohort of MSM

Author(s) -

Cheríe Blair,

Matthew R. Beymer,

Ryan Kofron,

Robert Bolan,

Wilbert Jordan,

Richard Haubrich,

Amy Rock Wohl,

Raphael J. Landovitz

Publication year - 2020

Publication title -

open forum infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.546

H-Index - 35

ISSN - 2328-8957

DOI - 10.1093/ofid/ofaa329

Subject(s) - medicine , dosing , men who have sex with men , pre exposure prophylaxis , cohort , human immunodeficiency virus (hiv) , syphilis , family medicine

Among a cohort of men who have sex with men in a pre-exposure prophylaxis (PrEP) adherence trial, syphilis requiring treatment was associated with white coat dosing (increased PrEP adherence immediately preceding study visits) when compared with participants with optimal drug concentrations. The findings highlight the need for identifying and reducing barriers to PrEP adherence.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research